Pre-implantation Genetic Testing
Identifying embryos with healthy genetics improves the chance of having a successful pregnancy. Pre-implantation Genetic Diagnosis (PGD) more recently referred to as Pre-implantation Genetic Testing (PGT), is a method of testing embryos so that we can detect embryos at reduced chance of chromosomal or genetic disorders prior to implantation and pregnancy.
Since its introduction, Melbourne IVF’s PGT programme has helped hundreds of couples and individuals conceive healthy babies through IVF treatment.
At Melbourne IVF we can test the embryos in a number of different ways, depending on the particular circumstances.
PGT-A (Pre-implantation Genetic Testing - Aneuploidy) identifies embryos with the right number of chromosomes
PGT-M (Pre-implantation Genetic Testing - Monogenic) identifies embryos free from single gene disorders
PGT-SR (Pre-implantation Genetic Testing - Structural Rearrangements) identifies embryos free from extra or missing segments of chromosomes
Pioneering science in PGT
Dr Sharyn Stock-Myer
Dr Sharyn Stock-Myer leads the Pre-implantation genetics team at Melbourne IVF. She holds a doctorate in Human Genetics and has worked at Melbourne IVF for many years, leading the development of PGT for monogenic disorders. Throughout this time, Dr Stock-Myer has developed more than 200 specific single gene tests and helped hundreds of couples avoid the transmission of a serious genetic condition to their offspring. Dr Stock-Myer has also led the research project that saw the introduction of karyomapping, a new test to screen for known genetic disorders introduced at Melbourne IVF in 2014. Sharyn is passionate about genes and genetic disorders and is honoured to be able to assist couples in their dream to have a healthy child.